TOC
Home > Research areas > Register Research in Rheumatology
  • Programme Area 2

Register Research in Rheumatology

  • Data-Linkage
  • Digital Rheumatology
  • Disease register
  • Spondyloarthritides

How can we use data from medical registers for evidence generation?

Medical registers, alongside clinical studies, are important tools in the research of new therapies and in improving and verifying already established treatment procedures. At the DRFZ, various registers have been successfully conducted nationwide for years. The methodological development of our registers is an important goal of our working group. The expertise of the program area will be utilized to optimize the currently running registers and, if necessary, establish new registers.

In addition to the main project RABBIT-SpA, the working group is focused on the further development of registers. For example, a process for integrating a medical smartphone app has been planned and implemented. Another milestone was the implementation of a data protection-compliant process for uploading imaging files into the register. Further innovative projects include the integration of RABBIT-SpA with the documentation software for rheumatology, RheDAT. A great potential lies in data linkage, which means the direct connection of register data with other data sources. Currently, a pilot project is underway to link RABBIT data with cancer register data. Other potential data sources for linkage include billing data and other medical registers.

Team

+49 (0)30 28460-635
anne.regierer@drfz.de

+49 (0)30 28460-665
stephanie.lembke@drfz.de

+49 (0)30 28460-636
lisa.lindner@drfz.de

+49 (0)30 28460-636
inken.padberg@drfz.de

+49 (0)30 28460-636
andreas.reich@drfz.de

+49 (0)30 28460-636
weiss@drfz.de

+49 (0)30 28460-636/-639
josephin.baumert@drfz.de

+49 (0)30 28460-665
anja.georgi@drfz.de

+49 (0)30 28460-639
carina.wittkopp@drfz.de

Main cooperation partners

AG Strangfeld
AG Callhoff
AG Minden
Prof. Denis Poddubnyy, Dr. Fabian Proft (Charité Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, CBF)
Prof. Gerhard Krönke, PD David Simon (Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, CCM)

Prof. Xenofon Baraliakos, Prof. Uta Kiltz, Ruhr Universität Bochum, Rheumazentrum Ruhrgebiet, Herne
Prof. Frank Behrens, Frankfurt
Prof. Georg Schett, Erlangen
Dr. Martin Feuchtenberger, Burghausen
Prof. Hans-Martin Lorenz, Heidelberg
Sonja Froschauer, Theresia Muth, Berufsverband Deutscher Rheumatologen (BDRh)
Dr Silke Zinke, Berlin
Dr. Kirsten Karberg, Berlin
Prof Andreas Krause, Immanuel Hospital, Rheumatology and Clinical Immunology, Berlin
Prof. Christof Specker, Düsseldorf
Anna Voormann, German Society for Rheumatology (DGRh)
Prof. Mathias Augustin, Hamburg
PD Stefan Kleinert, Erlangen
Tobias Hartz, Krebsregister Niedersachsen
Philipp Kachel, Krebsregister Rheinland-Pfalz
Alexander Stahmann, MS-Register
Manuel Burkhardt, Mukoviszidose-Register
Sebastian Semler, TMF, Berlin

The RABBIT-SpA register is supported by long-term shared funding from various manufacturers of innovative drugs. The DRFZ has full academic freedom in conducting the register and publishing the results.

Abbvie, Amgen, Biocon Biologics, Biogen, Celltrion, Janssen-Cilag, Lilly, Novartis, Pfizer, UCB.

EuroSpA: European collaboration of SpA registries, Prof. Merete Hetland (Kopenhagen)